Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

Peer Review reports

Original Submission
24 Oct 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
5 Dec 2013	Reviewed	Reviewer Report - DAVID DABBS
20 Jan 2014	Reviewed	Reviewer Report - Isabella Castellano
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
12 Feb 2014	Editorially accepted
13 Mar 2014	Article published	10.1186/1471-2407-14-177

Back to article page